Rapaflo and Ventolin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rapaflo (silodosin) and Ventolin (albuterol). Common drug interactions include aggression among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Rapaflo and Ventolin. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Rapaflo?

Rapaflo has active ingredients of silodosin. It is often used in prostate examination abnormal. eHealthMe is studying from 3,929 Rapaflo users. Check the latest studies of Rapaflo.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.



On Jul, 13, 2026

22 people who take Rapaflo and Ventolin together, and have interactions are studied.

Rapaflo and Ventolin drug interactions.

What are the common drug interactions of Rapaflo and Ventolin, by gender? *:

female:

  1. Aggression
  2. Decreased appetite
  3. Delusion (a false belief or opinion)
  4. Disinhibition (loss of inhibition)
  5. Disturbance in attention
  6. Energy increased
  7. Insomnia (sleeplessness)
  8. Mania (a state of abnormally elevated or irritable mood)
  9. Psychomotor hyperactivity (feelings of extreme restlessness)
  10. Weight decreased

male:

  1. Cardiac arrest
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Diarrhoea
  4. Chest discomfort
  5. Heat stroke
  6. Overdose
  7. Aphthous ulcer (mouth ulcer)
  8. Asthenia (weakness)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Balance disorder

What are the common drug interactions of Rapaflo and Ventolin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Body mass index increased
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  4. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  5. Diabetic vascular disorder (diseases of the blood vessels due to diabetes)
  6. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  7. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  8. Osteonecrosis (death of bone)
  9. Skin ulcer
  10. Stasis dermatitis (skin inflammation caused by blood pooling in the veins in your legs)

60+:

  1. Cardiac arrest
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Heat stroke
  4. Overdose
  5. Aggression
  6. Asthenia (weakness)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Balance disorder
  9. Brain natriuretic peptide increased
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.64%
  2. Pain: 2 people, 9.09%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 9.09%
  4. High Blood Pressure: 2 people, 9.09%
  5. High Blood Cholesterol: 2 people, 9.09%
  6. Diabetes: 2 people, 9.09%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Rapaflo and Ventolin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rapaflo and Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rapaflo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rapaflo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ventolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on silodosin and albuterol (the active ingredients of Rapaflo and Ventolin, respectively), and Rapaflo and Ventolin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: